ArticleBMJ open diabetes research & care2016

PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment.

Giulia Buonaiuto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.